Availability of Investigational Medicines Through the US Food and Drug Administration’s Expanded Access and Compassionate Use Programs-Reference-Cited by-同舟云学术

Availability of Investigational Medicines Through the US Food and Drug Administration’s Expanded Access and Compassionate Use Programs

Author:

Puthumana Jeremy¹,Miller Jennifer E.²,Kim Jeanie³,Ross Joseph S.⁴⁵⁶

Affiliation:

1. Yale School of Medicine, New Haven, Connecticut

2. Division of Medical Ethics, Department of Population Health, New York University School of Medicine, Bioethics International, New York

3. Collaboration for Research Integrity and Transparency (CRIT), Yale Law School, New Haven, Connecticut

4. Section of General Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut

5. Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut

6. Center for Outcomes Research and Evaluation, Yale–New Haven Hospital, New Haven, Connecticut

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

Reference7 articles.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献